menu Search
Kracid

Kracid

clarithromycin

Manufacturer:

Fredun Pharmaceuticals

Distributor:

Khriz Pharma
Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing
Concise Prescribing Info
Contents
Clarithromycin
Indications/Uses
Lower resp tract infections (eg, acute & chronic bronchitis, & pneumonia) & URTI (eg, sinusitis & pharyngitis). Initial therapy in community acquired resp infections. Skin & soft tissue infections of mild to moderate severity eg, folliculitis, cellulitis, erysipelas. Eradication of H. pylori in patients w/ duodenal ulcers.
Click to view Kracid detailed prescribing information
Dosage/Direction for Use
Resp tract/skin & soft tissue infection Adult 250 mg bid, may be increased to 500 mg bid in severe infections. Duration of treatment: 6-14 days. Childn >12 yr Same w/ adult dose. Eradication of H. pylori in patient w/ duodenal ulcers Adult Duration of treatment: 6-14 days. Triple therapy: Clarithromycin 500 mg bid & lansoprazole 30 mg bid w/ amoxicillin 1,000 mg bid; or clarithromycin 500 mg bid & lansoprazole 30 mg bid w/ metronidazole 400 mg bid; or clarithromycin 500 mg bid & omeprazole 40 mg daily w/ amoxicillin 1,000 mg bid or metronidazole 400 mg bid; or clarithromycin 500 mg bid & omeprazole 20 mg daily w/ amoxicillin 1,000 mg bid. Elderly Same w/ adult dose. Patient w/ renal impairment CrCl <30 mL/min Reduce dose by ½ ie, 250 mg once daily or 250 mg bid in more severe infections. Do not continue treatment beyond 14 days.
Click to view Kracid detailed prescribing information
Overdosage
View Kracid overdosage for action to be taken in the event of an overdose.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity to clarithromycin or macrolides. Patients w/ history of QT prolongation (congenital or documented acquired QT prolongation) or ventricular cardiac arrhythmia, including torsades de pointes. Concomitant use w/ ergot alkaloids (eg, ergotamine or dihydroergotamine); oral midazolam; astemizole, cisapride, pimozide & terfenadine; ticagrelor or ranolazine.
Click to view Kracid detailed prescribing information
Special Precautions
May select for drug-resistant organisms in the treatment of H. pylori infection. Patients w/ severe renal insufficiency; hepatic impairment; moderate to severe renal impairment. Pregnancy (particularly during 1st trimester) & lactation. Not recommended for childn <12 yr.
Click to view Kracid detailed prescribing information
Use In Pregnancy & Lactation
Click to view Kracid detailed prescribing information
Adverse Reactions
Insomnia; dysgeusia, headache, taste perversion; diarrhoea, vomiting, dyspepsia, nausea, abdominal pain; abnormal LFT; rash, hyperhidrosis.
Click to view Kracid detailed prescribing information
Drug Interactions
QT prolongation & cardiac arrhythmias including ventricular tachycardia, ventricular fibrillation & torsades de pointes w/ cisapride, pimozide, astemizole & terfenadine.
Click to view Kracid detailed prescribing information
Storage
View Kracid storage conditions for details to ensure optimal shelf-life.
Description
View Kracid description for details of the chemical structure and excipients (inactive components).
Action
View Kracid mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Macrolides
ATC Classification
J01FA09 - clarithromycin ; Belongs to the class of macrolides. Used in the systemic treatment of infections.
Regulatory Classification
Rx
Presentation/Packing
Form
Kracid FC tab 500 mg
Packing/Price
100's